Phase 2 Study of Yimitasvir Phosphate Capsules
- First Posted Date
- 2018-03-08
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 129
- Registration Number
- NCT03458481
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
🇨🇳Renmin Hospital of Wuhan University, Wuhan, Hubei, China
🇨🇳The Second Hospital of Nanjing, Nanjing, Jiangsu, China
A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT03125876
- Locations
- 🇨🇳
Hospital of Blood Disease, Chinese Academy of Medical Sciences, Tianjin, China
The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT03092102
- Locations
- 🇺🇸
Covance Clinical Research Unit, Inc., Madison, Wisconsin, United States
© Copyright 2025. All Rights Reserved by MedPath